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ABSTRACT
Background: Characteristics of coronary vasospasm-related sudden cardiac death are not 
well understood. We aimed to compare the characteristics and clinical outcomes between 
coronary vasospasm and stenosis, in out-of-hospital cardiac arrest (OHCA) survivors, who 
underwent coronary angiogram (CAG).
Methods: We conducted a multicenter retrospective observational registry-based study at 
8 Korean tertiary care centers. Data of OHCA survivors undergoing CAG between 2010 and 
2015 were extracted. Patients were divided into vasospasm and stenosis (stenosis > 50%) 
groups based on CAG findings. The primary and the secondary outcomes were survival and 
a good neurologic outcome at 30 days after OHCA. Patients in the vasospasm and stenosis 
groups were propensity score matched.
Results: Of the 413 included patients, vasospasm and stenosis groups comprised 87 and 326 
patients, respectively. There were 279 (66.7%) survivors and 206 (49.3%) patients with good 
neurologic outcomes. The vasospasm group had better clinical characteristics for outcome 
(younger age, less diabetes and hypertension, more prehospital restoration of spontaneous 
circulation, higher Glasgow Coma Scale, less ST segment elevation, and less requirement 
of circulatory support). The vasospasm group had better survival (75/87 vs. 204/326, P < 
0.001) and good neurologic outcomes (62/87 vs. 144/326, P < 0.001). However, vasospasm 
was not independently associated with survival (odds ratio [OR], 0.980; 95% confidence 
interval [CI], 0.400–2.406) or neurologic outcomes (OR, 0.870; 95% CI, 0.359–2.108) after 
adjustment and vasospasm was not associated with survival and neurologic outcome in 
propensity score-matched cohorts.
Conclusion: Our analysis of propensity score-matched cohorts finds that vasospasm OHCA 
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survivors have survival and neurologic outcomes comparable with those of stenotic OHCA 
survivors.
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INTRODUCTION
Coronary artery disease accounts for approximately 80% of sudden cardiac arrest (SCA).1,2 
Of the coronary artery diseases, acute coronary syndrome with coronary stenosis due to 
atherosclerosis is principally related to SCA, while SCA related to coronary vasospasm is a 
minority.2 However, the Asian population has high incidence of variant angina or SCA related 
to coronary vasospasm,3-5 because they have a diffuse coronary vasomotor reactivity as 
compared to Caucasians.6 Apart from racial differences, recreational drug overdose-related 
death, which might be due to coronary vasospasm, is increasing.7-9 Therefore, coronary 
vasospasm is considered to be an important cause of SCA that cannot be ignored.
Coronary vasospasm, which is characterized by reversible ischemia without any structural 
pathology in the coronary arteries,10 can also lead to lethal arrhythmias, myocardial infarction, 
and SCA.11-14 Although vasospasm-related SCA is believed to have a better prognosis due to its 
pathogenesis, previous studies reported that out-of-hospital cardiac arrest (OHCA) survivors 
with coronary vasospasm etiology demonstrated considerable long-term mortality or major 
adverse events after cardiac arrest.13,14 Previous studies attempted to elucidate the significance 
of variant angina manifesting as OHCA. However, they only compared variant angina with and 
without SCA.13,14 Therefore, little is known about whether vasospasm-related SCA has better 
clinical outcomes than SCA due to stenotic coronary artery disease, which is the most common 
cause. To evaluate the characteristics and clinical outcomes of vasospasm-related SCA, it should 
be compared with atherosclerotic coronary artery syndrome-related SCA.
We hypothesized that OHCA due to coronary vasospasm would be different as compared to 
OHCA due to stenotic coronary artery disease. Therefore, we included OHCA survivors who 
underwent coronary angiography (CAG) and compared the survival and neurologic outcome 
30 days after cardiac arrest between the coronary vasospasm and stenosis groups. To examine 
whether a difference in outcome arises from clinical characteristics, we used propensity 
score-matching to balance the characteristics between the vasospasm and stenosis groups.
METHODS
Study design and population
This multicenter, retrospective, observational, registry-based study was conducted at 8 
tertiary university affiliated teaching hospitals in Korea. Data were extracted from registries 
of consecutive patients with OHCA since January 2010.15
We extracted OHCA survivors with presumed cardiac etiology who underwent CAG at any 
time during admission. We included patients who demonstrated > 50% stenotic coronary 
lesions or vasospasm on CAG between January 2010 and December 2015. The patients who 
had undergone a previous coronary artery bypass graft, had no stenotic coronary artery, or 
had minimal to ≤ 50% of coronary artery stenosis, were excluded.
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Management and data collection
An interventional cardiologist at each hospital decided the timing of CAG and judged 
the angiographic findings. This individual also planned medical treatment with/without 
percutaneous coronary intervention (PCI). During the study period, comatose OHCA 
patients underwent targeted temperature management (TTM) according to the standard 
protocols at each hospital. Target temperature of 33°C or 36°C was maintained for at least 24 
hours. After completion of the maintenance period, patients were rewarmed at a rate of 0.25 
to 0.5°C/hr. The attending physician decided about the use of vasopressors, nitrate, intra-
aortic balloon pump (IABP), or extracorporeal membrane oxygenation (ECMO) according to 
the status of patients.
We obtained the following data: age, gender, pre-existing illness, presence of a witness on 
collapse, bystander cardiopulmonary resuscitation (CPR), first monitored rhythm, time from 
collapse to return of spontaneous circulation (ROSC), prehospital ROSC, Glasgow Coma 
Scale (GCS) after ROSC, ST segment elevation on electrocardiogram, angiographic finding, 
ventricular fibrillation after CAG or PCI, requirement of vasopressor (norepinephrine, 
vasopressin, epinephrine, dopamine, and dobutamine), nitrate, IABP, ECMO, or TTM, 
survival and neurologic outcomes at 30 days after cardiac arrest.
Based on angiographic findings, patients were divided into either vasospasm or stenosis 
groups (> 50% stenosis on any coronary artery). The diagnosis of vasospasm was made with 
spontaneous coronary spasm on CAG or documented coronary spasm on an ergonovine 
provocation CAG.16 Patients with mixed vasospasm and stenotic lesions were designated 
to either the vasospasm or the stenosis group based on the dominant pathology, which was 
decided by the interventional cardiologist.
The primary outcome was survival 30 days after cardiac arrest and the secondary outcome 
was a good neurologic outcome 30 days after cardiac arrest. Neurologic outcome was 
measured using the cerebral performance category (CPC) scale and we defined good 
neurologic outcome as CPC 1 and 2.17
Statistical analysis
We described categorical variables as frequencies with percentages, and continuous variables 
as mean with standard deviation (SD) or median with interquartile range, according to 
normality testing. Comparisons between the vasospasm and stenosis groups were performed 
using the χ2 test or Fisher's exact test for categorical variables, and independent t-test or 
Mann-Whitney U test for continuous variables.
To reduce the selection bias and potential confounding factors in an observational study, we 
calculated a propensity score and performed matching between the vasospasm and stenosis 
groups. The propensity score was calculated using a multivariate logistic regression model 
based on variables, with P < 0.2 between vasospasm and stenosis groups (Table 1). Propensity 
score matching was performed in a one-to-one fashion between the two groups using calipers 
with a width equal to the SD of the logit of the propensity score. We examined the difference 
between the vasospasm and stenosis groups by calculating absolute standard differences. 
An absolute standardized difference ≥ 10% between the two groups was considered to be 
significant. We used the McNemar's test for categorical variables and Wilcoxon signed-rank or 
paired t-test for continuous variables, for comparison between the two groups in the propensity 
score-matched cohort.
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We used multivariate regression analysis to assess the association between the vasospasm 
group and clinical outcomes. All variables with P < 0.2 in univariate comparisons between 
survivors and non-survivors and between good and poor neurologic outcomes were included 
in the multivariate logistic regression model. We used a backward stepwise approach, 
sequentially eliminating variables with P > 0.10 to build a final model. Goodness of fit of 
the final model was evaluated using the Hosmer–Lemeshow test. We presented the logistic 
regression analyses results as odds ratio (OR) and 95% confidence interval (CI). We used 
the log-rank test to compare the length of survival until 30 days after cardiac arrest. Survival 
statistics at the end of 30 days after cardiac arrest were constructed using the Kaplan–Meier 
plot and compared with the log-rank test. We performed all analyses with SPSS version 18.0 
(IMB Corp., Armonk, NY, USA) and Stata version 13.1 (StataCorp., College Station, TX, USA). 
Statistical significance was set as two-sided P values < 0.05.
Ethics statement
The protocol of this study was based on the ethical standards of the Declaration of Helsinki 
and was approved by the Institutional Review Board of the Chonnam National University 
Hospital (CNUH-2016-246). Informed consent was waived due to the retrospective nature of 
the study. The OHCA registry enrolled adult non-traumatic OHCA survivors.
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Table 1. Characteristics of out-of-hospital cardiac arrest survivors compared with coronary vasospasm and coronary stenosis
Characteristics Total (n = 413) Vasospasm (n = 87) Stenosis (n = 326) P value ASD
Demographics
Age, yr 58.6 ± 12.4 51.8 ± 12.4 60.5 ± 11.8 < 0.001 0.760
Gender, men 335 (81.1) 67 (77.0) 268 (82.2) 0.271 0.090
Comorbidities
Hypertension 177 (42.9) 23 (26.4) 154 (47.2) < 0.001 0.335
Diabetes mellitus 111 (26.9) 4 (4.6) 107 (32.8) < 0.001 0.523
Acute myocardial infarction 33 (8.0) 6 (6.9) 27 (8.3) 0.672 0.020
Coronary artery disease 59 (14.3) 9 (10.3) 50 (15.3) 0.237 0.099
Congestive heart failure 12 (2.9) 2 (2.3) 10 (3.1) 1.000 0.037
Chronic kidney disease 21 (5.1) 2 (2.3) 19 (5.8) 0.272 0.104
Cardiac arrest characteristics
Witnessed 322 (78.0) 64 (73.6) 258 (79.1) 0.265 0.096
Bystander CPR 220 (53.3) 45 (51.7) 175 (53.7) 0.745 0.020
Initial shockable rhythm 263 (63.7) 58 (66.7) 205 (62.9) 0.731 0.079
Time from collapse to ROSC, min 28.0 (18.0–40.0), 409a 26.0 (19.0–36.0), 85a 29.0 (17.0–41.8), 324a 0.170 0.270
Prehospital ROSC 100 (24.2) 30 (34.5) 70 (21.5) 0.020 0.235
Characteristics after ROSC
GCS 3 (3–5), 383 4 (3–7), 84 3 (3–5), 299a < 0.001 0.428
ST segment Elevation 163 (39.5) 19 (21.8) 144 (44.2) < 0.001 0.367
VF after CAG or PCI 32 (7.7) 5 (5.7) 27 (8.3) 0.432 0.055
Treatment
Norepinephrine 155 (37.5) 24 (27.6) 131 (40.2) 0.031 0.213
Vasopressin 4 (1.0) 0 (0.0) 4 (1.2) 0.299 0.102
Epinephrine 78 (18.9) 10 (11.5) 68 (20.9) 0.047 0.196
Dopamine 175 (42.4) 32 (36.8) 143 (43.9) 0.235 0.117
Dobutamine 33 (8.0) 2 (2.3) 31 (9.5) 0.028 0.218
Nitrate 117 (28.3) 38 (43.7) 79 (24.2) < 0.001 0.344
IABP 47 (11.4) 3 (3.4) 44 (13.5) 0.009 0.241
ECMO 64 (15.5) 3 (3.4) 61 (18.7) 0.001 0.332
TTM 304 (73.6) 71 (81.6) 233 (71.5) 0.057 0.175
All data presented as mean ± standard deviation or median (interquartile range) for continuous variables, and number (%) for categorical variables.
ASD = absolute standardized difference, CPR = cardiopulmonary resuscitation, ROSC= restoration of spontaneous circulation, GCS = Glasgow Coma Scale, 
VF = ventricular fibrillation, CAG = coronary angiogram, PCI = percutaneous coronary intervention, IABP = intra-aortic balloon pump, ECMO = extracorporeal 
membrane oxygenation, TTM = targeted temperature management.
aIncluded number of patients for analysis.
RESULTS
Patient selection
A total of 676 OHCA survivors with presumed cardiac etiology underwent CAG during the 
study period; of them, 258 were excluded due to no vasospasm, no stenosis, or stenosis < 
50%. Of the remaining 418 patients, 89 were designated to the vasospasm group and 329 to 
the stenosis group, while 2 and 3 patients were excluded due to lack of outcome data in each 
group, respectively. Thus, 413 patients were included in the study (Fig. 1).
Comparison between coronary vasospasm and stenosis groups
Characteristics of the patients before propensity score matching are summarized in Table 1. The 
vasospasm group patients were younger, and less likely to have hypertension and diabetes. The 
vasospasm group achieved a higher rate of prehospital ROSC, had a higher GCS, and were less 
likely to have ST segment elevation on an electrocardiogram. The vasospasm group required 
lesser vasopressors, IABP, and ECMO, while they required more nitrates. The vasospasm group 
had a significantly higher survival and good neurologic outcome in the entire cohort (Fig. 2). 
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Adult OHCA survivors with presumed
cardiac etiology who underwent CAG
(n = 676)
No stenosis (n = 196)
Minimal stenosis (n = 49)
Previous CABG (n = 13)
















Fig. 1. Flow diagram of included patients. 








































































































Fig. 2. Survival and good neurologic outcome on 30 days after cardiac arrest between out-of-hospital cardiac arrest survivors with coronary vasospasm and with 
coronary stenosis. (A) Vasospasm group has higher survival and good neurologic outcome in the whole cohort. (B) Survival and neurologic outcome are not 
different between vasospasm and stenosis groups in the propensity score-matched cohort.
Survival analysis with the Kaplan-Meier plot shows better survival in the vasospasm group at the 
end of 30 days after cardiac arrest in the entire cohort (log-rank P < 0.001) (Fig. 3).
Comparison between coronary vasospasm and stenotic groups
There were 279 (67.6%) survivors and 206 (49.9%) patients who had good neurologic 
outcomes 30 days after cardiac arrest in the entire cohort. Table 2 demonstrates a comparison 
of characteristics between survivors and non-survivors and between good neurologic 
outcome and poor neurologic outcome groups. Survivors had a higher frequency of 
vasospasm than non-survivors (26.9% vs. 9.0%, P < 0.001). However, vasospasm was not 
independently associated with survival (OR, 0.980; 95% CI, 0.400–2.406) (Table 3). The 
use of dopamine, IABP, and ECMO was associated with decreased survival, while use of 
nitrate was associated with increased survival. The good neurologic outcome group had a 
higher frequency of vasospasm than the poor neurologic outcome group (30.1% vs. 12.1%, 
P < 0.001). However, the vasospasm group was not independently associated with a good 
neurologic outcome (OR, 0.870; 95% CI, 0.359–2.108) (Table 3). The use of dopamine, 
epinephrine, and IABP was associated with poor neurologic outcome, while the use of nitrate 
was associated with good neurologic outcome.
Propensity score matched cohort
After matching the propensity score, each group included 69 patients (Table 4). No variable was 
significantly different between the vasospasm and stenosis groups and the absolute standard 
difference in propensity score-matched cohort improved. Survival and good neurologic 
outcome were not different between the vasospasm and stenosis groups (Fig. 2). Survival 
analysis with a Kaplan-Meier plot showed similar survival in both groups in propensity score-
matched cohort (log-rank P = 0.299) (Fig. 3).
DISCUSSION
OHCA with vasospasm had affirmative clinical characteristics for survival and good 
neurologic outcome. However, in the propensity score-matched cohort, OHCA survivors with 
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Fig. 3. Kaplan-Meier plots until occurrence of all causes of mortality during 30 days after cardiac arrest in the vasospasm and stenosis groups. (A) The 
vasospasm group has higher cumulative survival than the stenosis group (P < 0.001) in the whole cohort. (B) Vasospasm and stenosis groups have similar 
cumulative survival in the propensity score-matched cohort (P = 0.299).
coronary vasospasm had 30-day survival and neurologic outcomes similar to those of OHCA 
survivors with coronary stenosis.
Vasospasm-related SCA differs in incidence according to race and is less frequent than SCA 
associated with acute coronary syndrome.2-5 In Tokyo, vasospasm-related OHCA was 11.0% 
(17/155) in OHCA survivors who underwent CAG.3 In Paris, the incidence of SCA related to 
vasospasm was 2.0% (31/1,557) in patients with a definite cardiac etiology.5 Nevertheless, 
in the present study, we reported a higher incidence of 13.1% (89/676) vasospasm-related 
OHCA survivors among those who underwent CAG than did previous works, indicating that 
vasospasm-related OHCA incidence might be underestimated. Delayed provocation test for 
the diagnosis of vasospasm in patients with normal coronary arteries on CAG right after 
ROSC, is usually performed for safety reasons. However, poor neurologic outcome patients 
who showed normal coronary arteries on CAG or did not undergo CAG after ROSC might 
have no further opportunity to undergo a provocation test.18 Therefore, an undiagnosed 
vasospasm could be underreported, suggesting that the possibility of vasospasm in OHCA 
survivors should be considered.
Variant angina develops at a younger age than the angina secondary to atherosclerosis and is 
known not to exhibit classic coronary risk factors.10 Patients with SCA related to vasospasm 
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Table 2. Characteristics stratified as per the primary and the secondary outcomes
Characteristics Survivors (n = 279) Non-survivors (n = 134) P value Good (n = 206) Poor (n = 207) P value
Demographics
Age, yr 56.3 ± 11.8 63.5 ± 12.3 < 0.001 54.5 ± 11.4 62.7 ± 12.0 < 0.001
Gender, men 230 (82.4) 105 (78.4) 0.321 174 (84.5) 161 (77.8) 0.083
Comorbidities
Hypertension 108 (38.7) 69 (51.5) 0.014 63 (30.6) 114 (55.1) < 0.001
Diabetes mellitus 60 (21.5) 51 (38.1) < 0.001 31 (15.0) 80 (38.6) < 0.001
Acute myocardial infarction 24 (8.6) 9 (6.7) 0.508 16 (7.8) 17 (8.2) 0.867
Coronary artery disease 42 (15.1) 17 (12.7) 0.520 29 (14.1) 30 (14.5) 0.904
Congestive heart failure 8 (2.9) 4 (3.0) 1.000 4 (1.9) 8 (3.9) 0.245
Chronic kidney disease 8 (2.9) 13 (9.7) 0.003 5 (2.4) 16 (7.7) 0.014
Cardiac arrest characteristics
Witnessed 224 (80.3) 98 (73.1) 0.101 174 (84.5) 148 (71.5) 0.001
Bystander CPR 153 (54.8) 67 (50.0) 0.356 123 (59.7) 97 (46.9) 0.009
Initial shockable rhythm 197 (70.6) 66 (49.3) < 0.001 166 (80.6) 97 (46.9) < 0.001
Time from collapse to ROSC, min 24.0 (15.0–33.0), 275a 38.0 (30.0–55.3), 134a < 0.001 21.0 (14.0–30.0), 204a 35.0 (25.5–51.0), 205a < 0.001
Prehospital ROSC 96 (34.4) 4 (3.0) < 0.001 93 (45.1) 7 (3.4) < 0.001
Characteristics after ROSC
GCS 3 (3–6), 259a 3 (3–3), 124a < 0.001 5 (3–7), 191a 3 (3–3), 192a < 0.001
ST segment elevation 102 (36.6) 61 (45.5) 0.081 73 (35.4) 90 (43.5) 0.095
VF after CAG or PCI 11 (3.9) 15 (15.7) < 0.001 7 (3.4) 25 (12.1) 0.001
Treatment
Norepinephrine 81 (29.0) 74 (55.2) < 0.001 42 (20.4) 113 (54.6) < 0.001
Vasopressin 1 (0.4) 3 (2.2) 0.102 1 (0.5) 3 (1.4) 0.623
Epinephrine 41 (14.7) 37 (27.6) 0.002 21 (10.2) 57 (27.5) < 0.001
Dopamine 91 (32.6) 84 (62.7) < 0.001 56 (27.2) 119 (57.5) < 0.001
Dobutamine 16 (5.7) 17 (12.7) 0.015 10 (4.9) 23 (11.1) 0.019
Nitrate 96 (34.4) 21 (15.7) < 0.001 74 (35.9) 43 (20.8) 0.001
IABP 18 (6.5) 29 (21.6) < 0.001 8 (3.9) 39 (18.8) < 0.001
ECMO 23 (8.2) 41 (30.6) < 0.001 16 (7.8) 48 (23.2) < 0.001
TTM 219 (78.5) 85 (63.4) 0.001 154 (74.8) 150 (72.5) 0.597
All data presented as mean ± standard deviation or median (interquartile range) for continuous variables, and number (%) for categorical variables.
CPR = cardiopulmonary resuscitation, ROSC = restoration of spontaneous circulation, GCS = Glasgow Coma Scale, VF = ventricular fibrillation, CAG = coronary 
angiogram, PCI = percutaneous coronary intervention, IABP = intra-aortic balloon pump, ECMO = extracorporeal membrane oxygenation, TTM = targeted 
temperature management.
aIncluded number of patients for analysis.
were younger and less likely to have diabetes mellitus compared to other acute coronary 
syndromes in a prospective, population-based registry of OHCA.5 We also found similar 
associations of vasospasm with diabetes and age in the present study (Table 1). Diabetes is 
a well-known risk factor for development of coronary atherosclerotic changes. Although 
endothelial dysfunction is a common link between diabetes and vasospasm,19,20 diabetes 
was not independently associated with vasospasm.21 Diabetes is not only a risk factor for 
occurrence of OHCA but also can mitigate the effect of TTM in cardiac arrest survivors after 
ROSC.22,23 Older age is independently associated with higher mortality and poor neurologic 
outcome in OHCA and/or in-hospital cardiac arrest survivors.24,25 Therefore, a lower 
incidence of diabetes and younger age seemed to play an important role in better outcomes 
following vasospasm compared to stenosis in the whole cohort, while the vasospasm and 
stenotic groups with similar incidence of diabetes and age in the propensity score-matched 
cohort showed no difference in survival and neurologic outcomes.
Initial shockable rhythm and time from collapse to ROSC are robust prognostic factors 
contributing to the outcome of cardiac arrest survivors.26,27 Coronary vasospasm can also 
induce life-threatening ventricular arrhythmias due to both transient myocardial ischemia 
and reperfusion.28 Previous works reported similar shockable rhythms in both vasospasm 
and non-vasospasm OHCA groups.3,5 The frequency of shockable rhythm and time from 
collapse to ROSC was not different between the vasospasm and stenosis groups in the present 
study. However, our findings demonstrated that the vasospasm group achieved higher 
prehospital ROSC which is a strong indicator of better outcome in OHCA. Higher prehospital 
ROSC in the vasospasm group is presumed to contribute to the higher GCS after ROSC, 
better survival, and better neurologic outcomes 30 days after cardiac arrest in the whole 
cohort of this study. Under circumstances of emergency medical services which provided 
only basic life support and defibrillation during the study period,29 the higher prehospital 
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Table 3. Multivariate logistic regression analyses for survival and good neurologic outcome on 30 days after cardiac arrest
Characteristics OR (95% CI) for survival P value OR (95% CI) for good neurologic outcome P value
Increase in age by year 0.965 (0.941–0.990) 0.006 0.971 (0.945–0.998) 0.033
Gender, men NA 1.476 (0.640–3.406) 0.361
Hypertension 1.116 (0.587–2.120) 0.738 0.437 (0.207–0.923) 0.030
Diabetes mellitus 0.900 (0.446–1.818) 0.769 0.323 (0.133–0.785) 0.013
Chronic kidney disease 0.396 (0.114–1.372) 0.144 3.956 (0.856–18.292) 0.078
Witness 1.688 (0.874–3.259) 0.119 2.520 (1.181–5.376) 0.017
Bystander cardiopulmonary resuscitation NA 1.595 (0.783–3.250) 0.198
Shockable rhythm 1.960 (1.051–3.653) 0.034 4.371 (2.102–9.089) < 0.001
Increase in time from collapse to ROSC by min 0.977 (0.959–0.995) 0.012 0.961 (0.942–0.980) < 0.001
Prehospital ROSC 7.280 (1.750–30.275) 0.006 6.268 (2.049–19.176) 0.001
Increase in GCS by score 1.237 (1.049–1.459) 0.011 1.348 (1.133–1.603) 0.001
ST segment elevation 0.671 (0.356–1.264) 0.217 0.610 (0.304–1.222) 0.163
VF after CAG or PCI 0.221 (0.072–0.672) 0.008 0.105 (0.024–0.457) 0.003
Norepinephrine 0.977 (0.512–1.866) 0.944 0.813 (0.387–1.708) 0.585
Vasopressin NA NA
Epinephrine 0.825 (0.402–1.694) 0.600 0.437 (0.197–0.969) 0.042
Dopamine 0.375 (0.204–0.689) 0.002 0.292 (0.148–0.578) < 0.001
Dobutamine 0.657 (0.257–1.678) 0.380 0.986 (0.302–3.216) 0.981
Nitrate 2.135 (1.066–4.275) 0.032 2.644 (1.289–5.421) 0.008
IABP 0.323 (0.136–0.767) 0.010 0.093 (0.024–0.357) 0.001
ECMO 0.340 (0.138–0.835) 0.019 1.097 (0.367–3.279) 0.869
TTM 3.704 (1.558–6.063) 0.001 NA
Vasospasm 0.980 (0.400–2.406) 0.966 0.870 (0.359–2.108) 0.757
OR = odds ratio, CI = confidence interval, NA = not applicable, ROSC = restoration of spontaneous circulation, GCS = Glasgow Coma Scale, VF = ventricular 
fibrillation, CAG = coronary angiogram, PCI = percutaneous coronary intervention, IABP = intra-aortic balloon pump, ECMO = extracorporeal membrane 
oxygenation, TTM = targeted temperature management.
ROSC in the vasospasm group was postulated to be related to the transient myocardial 
ischemic nature of vasospasm without any structural lesion in the coronary artery. However, 
on the contrary, the vasospasm and stenotic groups had comparable prehospital ROSC in 
the propensity score-matched cohort and showed similar clinical outcomes. The lesser ST 
segment elevation on electrocardiogram in the vasospasm group seems to be associated 
with lesser ischemic insult to the heart. Our findings demonstrated that lesser requirement 
of vasopressors, mechanical circulatory support in the vasospasm group is consistent with 
the assumption of more preserved heart function from ischemic insult than in the stenosis 
group.5 Likewise, the vasospasm and stenotic groups in the propensity score-matched cohort 
had no difference in ST segment elevation and circulatory support measures. This might be 
associated with the insignificant differences in survival and neurologic outcomes.
The adjusted ORs of the vasospasm group versus the stenosis group for 30-day survival 
and good neurologic outcomes were insignificant in the present study. The difference in 
the 30-day survival and neurologic outcomes between the vasospasm and stenosis group 
disappeared after balancing the characteristics between the two groups, as well. The 
covariates included a logistic regression model, and variables which were balanced through 
propensity score-matching in the present study are considered as the characteristics of 
vasospasm. Due to these characteristics, the vasospasm group can be expected to show 
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Table 4. Characteristics of out-of-hospital cardiac arrest survivors with coronary vasospasm and coronary stenosis in propensity score-matched cohort
Characteristics Total (n = 138) Vasospasm (n = 69) Stenosis (n = 69) P value ASD
Demographics
Age, yr 54.0 (47.0–60.3) 55.0 (47.5–60.5) 53.0 (46.0–60.5) 0.365 0.113
Gender, men 119 (86.2) 56 (81.2) 63 (91.3) 0.118 0.297
Comorbidities
Hypertension 37 (26.8) 20 (29.0) 17 (24.6) 0.701 0.098
Diabetes mellitus 6 (4.3) 4 (5.8) 2 (2.9) 0.625 0.143
Acute myocardial infarction 9 (6.5) 6 (8.7) 3 (4.3) 0.508 0.177
Coronary artery disease 15 (10.9) 8 (11.6) 7 (10.1) 1.000 0.047
Congestive heart failure 4 (2.9) 2 (2.9) 2 (2.9) 1.000 0.000
Chronic kidney disease 1 (0.7) 1 (1.4) 0 (0.0) NA 0.172
Cardiac arrest characteristics
Witnessed 106 (76.8) 49 (71.0) 57 (82.6) 0.200 0.277
Bystander CPR 82 (59.4) 38 (55.1) 44 (63.8) 0.362 0.178
Initial shockable rhythm 40 (29.0) 23 (33.3) 17 (24.6) 0.327 0.193
Time from collapse to ROSC, mins 25.5 (16.8–35.0), 134a 27.0 (20.0–38.0), 67a 25.0 (15.0–34.0), 67a 0.452 0.118
Prehospital ROSC 47 (34.1) 22 (31.9) 25 (36.2) 0.690 0.092
Characteristics after ROSC
GCS 3 (3–6) 3 (3–6) 3 (3–6) 0.218 0.146
ST segment elevation 39 (28.3) 19 (27.5) 20 (29.0) 1.000 0.032
VF after CAG or PCI 8 (5.8) 5 (7.2) 3 (4.3) 0.727 0.124
Treatment
Norepinephrine 41 (29.7) 20 (29.0) 21 (30.4) 0.720 0.032
Vasopressin 0 (0.0) 0 (0.0) 0 (0.0) NA NA
Epinephrine 16 (11.6) 8 (11.6) 8 (11.6) 1.000 0.000
Dopamine 58 (42.0) 30 (43.5) 28 (40.6) 0.860 0.059
Dobutamine 8 (5.8) 2 (2.9) 6 (8.7) 0.289 0.065
Nitrate 52 (37.7) 28 (40.6) 24 (34.8) 0.503 0.120
IABP 11 (8.0) 3 (4.3) 8 (11.6) 0.227 0.270
ECMO 5 (3.6) 3 (4.3) 2 (2.9) 1.000 0.078
TTM 109 (79.0) 57 (82.6) 52 (75.4) 0.458 0.179
All data presented as median (interquartile range) for continuous variables, and number (%) for categorical variables.
ASD = absolute standardized difference, CPR = cardiopulmonary resuscitation, ROSC= restoration of spontaneous circulation, GCS = Glasgow Coma Scale, VF = 
ventricular fibrillation, CAG = coronary angiogram, PCI = percutaneous coronary intervention, NA = not applicable, IABP = intra-aortic balloon pump, ECMO = 
extracorporeal membrane oxygenation, TTM = targeted temperature management.
aIncluded number of patients for analysis.
a better outcome. Vasospasm-related cardiac arrest is generally believed to have better 
outcome than coronary stenosis-related cardiac arrest.10,30 However, the result of the 
present study suggests that vasospasm-related cardiac arrest itself has a severity equivalent 
to coronary stenosis-related cardiac arrest. Even if findings such as younger age, lower risk 
of atherosclerosis, and transient myocardial ischemic characteristics suggest vasospasm-
related cardiac arrest, standard post-cardiac arrest care including CAG should be provided in 
accordance with coronary stenosis.
A previous study showed that the high dose vasopressor was associated with increased 
mortality in OHCA survivors.31 In line with the previous study, greater use of vasopressors or 
circulatory supports was associated with increased mortality and poor neurologic outcomes, 
irrespective of the presence of coronary vasospasm or stenosis in the present study. On the 
other hand, the association between nitrate and survival or good neurologic outcomes can be 
explained by the avoidance of nitrate in hypotensive or shock status.
This study has a few limitations. First, we included OHCA survivors who underwent delayed 
CAG due to the issue of safety for the provocation test. However, survivors with poor 
neurologic outcomes tended to undergo no further CAG to elucidate the cause of collapse, 
which may have led to a selection bias. Although the provocation test with acetylcholine 
or ergonovine is a confirmative diagnostic procedure for coronary vasospasm, not all 
patients in the vasospasm group were diagnosed using the provocation test. Future studies 
are warranted on OHCA with presumed cardiac etiology, who routinely received CAG and 
provocation tests (if required), to elucidate the true incidence of vasospasm-related SCA 
and the association between coronary pathology and outcomes. Second, we defined > 50% 
stenosis of the coronary artery as clinically significant stenosis. There is a debate on the 
threshold value of clinically significant stenosis from 50% to 75%,32-34 with 70% stenosis 
recently accepted as clinically significant. However, we presumed that > 50% coronary 
stenosis could be causative, because all patients in the present study were OHCA survivors 
without any obvious extra-cardiac causes. Third, we designated the patients with mixed 
vasospasm and stenotic lesions based on the dominant pathology, which might have 
produced bias. Fourth, owing to the retrospective observational study design, we could only 
identify an association but not causation between vasospasm and clinical outcomes. Fifth, 
we performed propensity score-matching to balance the intergroup differences. However, 
intergroup differences could still have been possible. Sixth, although the attending physician 
provided post-resuscitation care according to the standard protocols of each hospital, 
the difference in infrastructure among hospitals may be a potential confounding factor. 
Seventh, we were not able to address the location and severity of coronary vasospasm and 
treatment, such as calcium channel blocker and implantation of intracardiac defibrillator, 
due to a lack of data. Eighth, the results generated by the present study cannot be generalized 
because vasospasm is disproportionately prevalent within Asian—compared to Caucasian—
populations. Ninth, we did not analyze the association between details of vasopressors (dose, 
timing, and retention) and outcomes due to the lack of data.
In conclusion, vasospasm-related OHCA survivors have good baseline and cardiac arrest 
characteristics, which are responsible for better survival and good neurologic outcome 
30 days after cardiac arrest. However, vasospasm-related OHCA survivors have survival 
and neurologic outcomes similar to stenosis-related OHCA survivors after adjustment or 
balancing the characteristics.
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